Loading...
research article
Boosting dendritic cell nanovaccines
April 11, 2022
A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.
Use this identifier to reference this record
Type
research article
Web of Science ID
WOS:000780825800003
Authors
Publication date
2022-04-11
Publisher
Published in
Volume
17
Start page
442
End page
444
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
April 25, 2022